中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2009年
7期
58-60
,共3页
李文涛%刘蕊%程颖博%刘梅%吴庆庆
李文濤%劉蕊%程穎博%劉梅%吳慶慶
리문도%류예%정영박%류매%오경경
急性心肌梗死%卫生保健质量%溶栓治疗
急性心肌梗死%衛生保健質量%溶栓治療
급성심기경사%위생보건질량%용전치료
Myocardial infarction%Acute%Health care quality%Fibrinolytic therapy
目的 了解近五年栾川县医院急性心肌梗死(AMI)患者的住院治疗状况.方法 调查栾川县医院2002~2006年出院诊断为AMI,住院时间>24 h患者的病史资料,调查各种西医治疗措施应用情况.结果 共调查了265例患者,早期再灌注治疗率为17.7%,均为溶栓治疗.适宜溶栓率为37.4%,适宜溶栓者中52.5%没有接受任何形式的早期再灌注治疗.β受体阻滞剂和血管紧张素转换酶抑制剂的适宜使用率分别为61.1%和70.9%,实际使用率分别为38.1%和42.6%,他汀类药物的使用率为37.7%,阿司匹林、低分子肝素、硝酸酯使用率分别为92.8%、69.8%、89.8%.结论 2002~2006年栾川县医院AMI患者治疗情况与2001年中华医学会心血管病学分会AMI诊断和治疗指南的要求存在明显差距.
目的 瞭解近五年欒川縣醫院急性心肌梗死(AMI)患者的住院治療狀況.方法 調查欒川縣醫院2002~2006年齣院診斷為AMI,住院時間>24 h患者的病史資料,調查各種西醫治療措施應用情況.結果 共調查瞭265例患者,早期再灌註治療率為17.7%,均為溶栓治療.適宜溶栓率為37.4%,適宜溶栓者中52.5%沒有接受任何形式的早期再灌註治療.β受體阻滯劑和血管緊張素轉換酶抑製劑的適宜使用率分彆為61.1%和70.9%,實際使用率分彆為38.1%和42.6%,他汀類藥物的使用率為37.7%,阿司匹林、低分子肝素、硝痠酯使用率分彆為92.8%、69.8%、89.8%.結論 2002~2006年欒川縣醫院AMI患者治療情況與2001年中華醫學會心血管病學分會AMI診斷和治療指南的要求存在明顯差距.
목적 료해근오년란천현의원급성심기경사(AMI)환자적주원치료상황.방법 조사란천현의원2002~2006년출원진단위AMI,주원시간>24 h환자적병사자료,조사각충서의치료조시응용정황.결과 공조사료265례환자,조기재관주치료솔위17.7%,균위용전치료.괄의용전솔위37.4%,괄의용전자중52.5%몰유접수임하형식적조기재관주치료.β수체조체제화혈관긴장소전환매억제제적괄의사용솔분별위61.1%화70.9%,실제사용솔분별위38.1%화42.6%,타정류약물적사용솔위37.7%,아사필림、저분자간소、초산지사용솔분별위92.8%、69.8%、89.8%.결론 2002~2006년란천현의원AMI환자치료정황여2001년중화의학회심혈관병학분회AMI진단화치료지남적요구존재명현차거.
Objective To investigate the treatment status of hospitalized patients with acute myocardial infarction (AMI) in Luanehuan county hospital. Methods The data of hospitalized patients with AMI discharged between January 2002 and December 2006 were retrospectively collected from medical records of Luanchuan county hospital. All patients with a diagnosis of AMI and a more than 24 hours hospitalization were included. We assessed the use of western medicine. Results A total of 265 patients were included. Reperfusian were per-formed in 17.7% of the patients, all for fibrinolytic therapy. 37.4% of the patients are suitable for fibrinolytic therapy ,52. 5% patients did not receive any reperfusion treatment. Among the patients,61.1% were eligible for beta blockers(BB) and 70. 9% for angiotensin converting enzyme inhibitors(ACEI), but only 38.1% were actu-ally treated with BB and 42. 6% with ACEI. 37.7% of the patients received statins. The utilization rates of aspi-rin, low-molecular-weight beparin, nitrates were 92.8%, 69.8%, 89.8% respectively. Conclusion There is a great gab between the therapy carried out in the hospital of luanchuan county in 2002-2006 and the Chinese Medical Association guidelines for AMI in 2001.